Eli Silber

5.5k total citations
81 papers, 2.6k citations indexed

About

Eli Silber is a scholar working on Pathology and Forensic Medicine, Neurology and Sociology and Political Science. According to data from OpenAlex, Eli Silber has authored 81 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pathology and Forensic Medicine, 23 papers in Neurology and 13 papers in Sociology and Political Science. Recurrent topics in Eli Silber's work include Multiple Sclerosis Research Studies (43 papers), Family Support in Illness (13 papers) and Palliative Care and End-of-Life Issues (12 papers). Eli Silber is often cited by papers focused on Multiple Sclerosis Research Studies (43 papers), Family Support in Illness (13 papers) and Palliative Care and End-of-Life Issues (12 papers). Eli Silber collaborates with scholars based in United Kingdom, United States and Italy. Eli Silber's co-authors include Irene J Higginson, Rachel Burman, Polly Edmonds, Sam Hart, Biba Stanton, Bella Vivat, Rona Moss‐Morris, Mohammad K. Sharief, M. K. Sharief and Paul McCrone and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Eli Silber

78 papers receiving 2.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Eli Silber 1.2k 710 532 320 295 81 2.6k
Deborah Miller 2.2k 1.8× 333 0.5× 729 1.4× 257 0.8× 416 1.4× 84 3.9k
William Likosky 1.4k 1.2× 186 0.3× 526 1.0× 290 0.9× 408 1.4× 25 2.6k
Tuula Tyry 2.8k 2.3× 237 0.3× 487 0.9× 232 0.7× 269 0.9× 83 3.7k
Jamshid Ahmadi 521 0.4× 743 1.0× 963 1.8× 444 1.4× 101 0.3× 220 4.5k
Peter Joseph Jongen 1.2k 1.0× 138 0.2× 508 1.0× 308 1.0× 183 0.6× 95 3.0k
Eugenio Pucci 974 0.8× 283 0.4× 330 0.6× 146 0.5× 186 0.6× 75 2.2k
Denise I. Campagnolo 2.3k 1.9× 352 0.5× 586 1.1× 101 0.3× 561 1.9× 80 4.0k
Paul G. Ritvo 1.6k 1.3× 105 0.1× 593 1.1× 178 0.6× 225 0.8× 17 3.4k
June Halper 2.6k 2.1× 253 0.4× 855 1.6× 115 0.4× 485 1.6× 71 3.1k
Frederick W. Foley 2.2k 1.8× 112 0.2× 433 0.8× 280 0.9× 150 0.5× 103 2.9k

Countries citing papers authored by Eli Silber

Since Specialization
Citations

This map shows the geographic impact of Eli Silber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli Silber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Silber more than expected).

Fields of papers citing papers by Eli Silber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eli Silber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli Silber. The network helps show where Eli Silber may publish in the future.

Co-authorship network of co-authors of Eli Silber

This figure shows the co-authorship network connecting the top 25 collaborators of Eli Silber. A scholar is included among the top collaborators of Eli Silber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eli Silber. Eli Silber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Muraro, Paolo A., Antonio Zito, Alessio Signori, et al.. (2025). Effectiveness of Autologous Hematopoietic Stem Cell Transplantation versus Alemtuzumab and Ocrelizumab in Relapsing Multiple Sclerosis: A Single Center Cohort Study. Annals of Neurology. 98(2). 294–307. 4 indexed citations
2.
Muraro, Paolo A., Eleonora De Matteis, Gavin Brittain, et al.. (2025). Real-world effectiveness of autologous haematopoietic stem cell transplantation for multiple sclerosis in the UK. Journal of Neurology Neurosurgery & Psychiatry. 97(2). jnnp–2025.
3.
Palmer, David A., Hannah C. Dooley, Menelaos Pipis, Piers Patten, & Eli Silber. (2022). A Novel approach using O-CVP to treat paraneoplastic NMO spectrum disorder associated with follicular lymphoma. BMJ Case Reports. 15(11). e252822–e252822.
4.
Reen, Gurpreet, Eli Silber, & Dawn Langdon. (2021). Improving MS patients’ understanding of treatment risks and benefits in clinical consultations: A randomised crossover trial. Multiple Sclerosis and Related Disorders. 49. 102737–102737. 2 indexed citations
5.
Silber, Eli, et al.. (2021). COVID-19 leukoencephalopathy with subacute magnetic resonance imaging findings of vasculitis and demyelination. Journal of NeuroVirology. 27(4). 656–661. 1 indexed citations
6.
Hepgul, Nilay, Rebecca Wilson, Deokhee Yi, et al.. (2020). Immediate versus delayed short-term integrated palliative care for advanced long-term neurological conditions: the OPTCARE Neuro RCT. SHILAP Revista de lepidopterología. 8(36). 1–80. 4 indexed citations
7.
Evans, Catherine, Eli Silber, Rachel Burman, et al.. (2020). A realist review of advance care planning for people with multiple sclerosis and their families. PLoS ONE. 15(10). e0240815–e0240815. 18 indexed citations
8.
9.
Carotenuto, Antonio, Beniamino Giordano, George Dervenoulas, et al.. (2019). [18F]Florbetapir PET/MR imaging to assess demyelination in multiple sclerosis. European Journal of Nuclear Medicine and Molecular Imaging. 47(2). 366–378. 20 indexed citations
10.
Reen, Gurpreet, Eli Silber, & Dawn Langdon. (2018). Best Methods of Communicating Clinical Trial Data to Improve Understanding of Treatments for Patients with Multiple Sclerosis. Value in Health. 21(7). 762–766. 7 indexed citations
11.
Silber, Eli, et al.. (2017). The spectrum of psychosis in multiple sclerosis: a clinical case series. Neuropsychiatric Disease and Treatment. Volume 13. 303–318. 13 indexed citations
12.
Reen, Gurpreet, Eli Silber, & Dawn Langdon. (2016). Multiple sclerosis patients' understanding and preferences for risks and benefits of disease-modifying drugs: A systematic review. Journal of the Neurological Sciences. 375. 107–122. 40 indexed citations
13.
Reen, Gurpreet, Eli Silber, & Dawn Langdon. (2016). Interventions to support risk and benefit understanding of disease-modifying drugs in Multiple Sclerosis patients: A systematic review. Patient Education and Counseling. 100(6). 1031–1048. 10 indexed citations
14.
Koffman, Jonathan, Cassie Goddard, Wei Gao, et al.. (2015). Exploring meanings of illness causation among those severely affected by multiple sclerosis: a comparative qualitative study of Black Caribbean and White British people. BMC Palliative Care. 14(1). 13–13. 9 indexed citations
15.
Askey‐Jones, Sally, et al.. (2013). Cognitive behaviour therapy for common mental disorders in people with Multiple Sclerosis: A bench marking study. Behaviour Research and Therapy. 51(10). 648–655. 25 indexed citations
16.
Askey‐Jones, Sally, et al.. (2012). A nurse-led mental health service for people with multiple sclerosis. Journal of Psychosomatic Research. 72(6). 463–465. 7 indexed citations
17.
Crocker, Matthew, et al.. (2008). Neurosarcoidosis presenting as ghost lesions in the CNS: a diagnostic dilemma. British Journal of Hospital Medicine. 69(2). 108–109. 1 indexed citations
18.
Higginson, Irene J, Sam Hart, Rachel Burman, et al.. (2008). Randomised controlled trial of a new palliative care service: Compliance, recruitment and completeness of follow-up. BMC Palliative Care. 7(1). 7–7. 42 indexed citations
19.
Stanton, Biba, et al.. (2006). Sleep and fatigue in multiple sclerosis. Multiple Sclerosis Journal. 12(4). 481–486. 181 indexed citations
20.
Abbott, Rachel, et al.. (2005). Osmotic demyelination syndrome. BMJ. 331(7520). 829–830. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Deborah Miller Breakdown of academic impact, for papers by William Likosky Breakdown of academic impact, for papers by Tuula Tyry Breakdown of academic impact, for papers by Jamshid Ahmadi Breakdown of academic impact, for papers by Peter Joseph Jongen Breakdown of academic impact, for papers by Eugenio Pucci Breakdown of academic impact, for papers by Denise I. Campagnolo Breakdown of academic impact, for papers by Paul G. Ritvo Breakdown of academic impact, for papers by June Halper Breakdown of academic impact, for papers by Frederick W. Foley
Rankless by CCL
2026